Ironwood PharmaceuticalsvsMerck & Company

IRWD and MRK stock compared: price, dividend, valuation and results, from SEC filings.

IRWD

Ironwood Pharmaceuticals, Inc.

$4.70

Value $766M

-1.78%
IRWD's page

MRK

Merck & Company, Inc.

$132.13

Value $327B

-3.95%
MRK's page

Ironwood Pharmaceuticals (IRWD) has a market value of $766M and Merck & Company (MRK) $327B. Over the last year, with dividends, IRWD moved +51.1% and MRK +41.2%. The P/E is 5.1 for IRWD and 133.2 for MRK. Dividend yield: IRWD none, MRK 2.57%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    IRWD$766M

    MRK$327B

    MRK is 427 times IRWD

  • Revenue, 12 months

    IRWD$400M

    MRK$67.4B

    MRK is 168 times IRWD

  • Net income, 12 months

    IRWD$150M

    MRK$2.5B

    MRK is 16 times IRWD

  • Operating margin

    IRWD62.9%

    MRK–

  • ROIC

    IRWD83.7%

    MRK3.9%

    79.8 points apart

  • P/E

    IRWD5.1

    MRK133.2

    MRK is 26 times IRWD

  • Dividend yield

    IRWD0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    IRWD-60.4%

    MRK+85.6%

    146.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

IRWD-60.4%

MRK+85.6%

010020020222023202420252026
Returns by period
PeriodIRWDWith dividendsMRKWith dividends
1 year since November 18, 2025+51.1%Price +51.1%+41.2%Price +37.2%
3 years since November 17, 2023-51.9%-21.7% a yearPrice -51.9%+42.5%+12.5% a yearPrice +30.0%
5 years since November 18, 2021-60.4%-16.9% a yearPrice -60.4%+85.6%+13.2% a yearPrice +59.3%
10 years since November 21, 2016-65.8%-10.2% a yearPrice -65.8%+202.0%+11.7% a yearPrice +122.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

IRWDIronwood PharmaceuticalsMRKMerck & Company

Valuation

IRWDMRK
Valuation
Price$4.70$132.13
Market value$766M$327B
Enterprise value (EV)$1.0B$371B
P/E5.1133.2
P/E, 5-year median12.914.8
P/B–7.3
EV/EBIT4.077.9
Free cash flow yield26.8%4.5%

Results and growth

IRWDMRK
Results and growth
Revenue, 12 months$400M$67.4B
Net income, 12 months$150M$2.5B
Free cash flow, 12 months$205M$14.7B
Earnings per share, 12 months$0.90$0.98
Revenue growth, year on year-15.7%1.3%
Revenue growth a year, past-5.3%over 5 years+9.4%over 5 years
EPS growth a year, past-25.7%over 5 years+21.2%over 5 years

Margins and returns on capital

IRWDMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin62.9%–
Net margin37.4%3.6%
ROIC83.7%3.9%
ROE–5.2%

Balance sheet

IRWDMRK
Balance sheet
Cash$86M$9.7B
Total debt$336M$53.8B
Net debt / EBITDA0.95.7
Interest cover8.3×2.4×

Dividends and buybacks

IRWDMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: IRWD or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Ironwood Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($327B) is about 426.7 times Ironwood Pharmaceuticals ($766M), at today's prices.

How did IRWD and MRK stock do over the last 10 years?

Since November 21, 2016, IRWD's price moved -65.8% and MRK's +122.5%. With dividends: IRWD -65.8% (-10.2% a year), MRK +202.0% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, IRWD or MRK?

The dividend yield at today's price is none for Ironwood Pharmaceuticals and 2.57% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of IRWD and MRK?

At today's price, the P/E is 5.1 for IRWD and 133.2 for MRK. The median of the last five years was 12.9 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Ironwood Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 37.4% for Ironwood Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 62.9% and –. Revenue was $400M and $67.4B.

Which is the better investment, Ironwood Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.